We are delighted to announce the well-deserved promotion of Francesco Draetta to Managing Director. This promotion acknowledges his outstanding leadership, significant contributions, and steadfast commitment to Omega’s values. Congratulations Francesco!
Delighted to announce the promotion of Francesco Draetta to Managing Director at Omega: a just reward for his many contributions to the firm across all our activities. Please join me and our whole team in congratulating him!
Vice President (Queen of Massachusetts) - Executive Search at Raw Selection | Securing Private Equity professionals for PE firms across Massachusetts & the US | haleema.hussain@raw-selection.com
Massachusetts PE news in February 📣 📍 Charlesbank Capital Partners takes over as the lead investor in Perspective Financial Group, succeeding CBPE Capital, signaling a strategic shift in ownership. 📍 Berkshire Partners-backed AHEAD acquires CDI, solidifying its position as a dominant force in the global digital platforms market with a combined entity valued at $3.7 billion. 📍 Sanofi Ventures backed Sudo Biosciences secures $147 million in Series B financing from notable investors like Dementia Discovery Fund, Leaps by Bayer, and UPMC Enterprises, highlighting significant interest in its precision TYK2 inhibitors. 📍 Nordic Capital's acquisition of a majority stake in ActiveViam underscores the growing demand for data analytics in financial risk management, particularly amidst regulatory changes and the rise of big data. As part of the transaction, Guidepost Growth Equity, which first invested in ActiveViam in 2019, will sell all of its shares. 📍 Totango and Catalyst's merger, supported by Great Hill Partners, creates a robust customer growth platform, integrating enterprise customer success software with advanced analytics and AI capabilities to drive revenue growth from existing customers, reflecting a strategic response to evolving market demands #privateequity #massachusetts #mergersandacquisitions
Cannara Biotech Inc. (TSX-V:LOVE, OTCQB:LOVFF) CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the #cannabis industry during an interview with Steve Darling from Proactive. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square feet, with a strong focus on quality and cost-efficiency, thanks in part to Quebec's low electricity costs. Sosiak discussed the company's strategic acquisitions, including the purchase of a 1 million square foot cannabis facility for $27 million, significantly below its initial cost. Cannara Biotech Inc. has also developed three in-house brands: Tribal, Nugs, and Orchid CBD, each catering to specific market niches. The company places a strong emphasis on consistency and quality to drive brand loyalty among consumers. Watch at #Proactive #ProactiveInvestors #TSXV #OTCQB #LOVE #LOVFF http://ow.ly/5Pvs1059jEg
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma
Thank you for sharing our story BudsFeed! Silver Therapeutics Co-Founder, CFO & COO Brendan McKee shares how it all started, and how the company was built on compassion from the very beginning. Check out the full article below!
As part of our “How It Started” interview series, we had the pleasure of chatting with Brendan McKee, Co-Founder, CFO & COO of Silver Therapeutics, a New England cannabis curator and privately-held multi-state operator. With locations in Maine, Massachusetts, Vermont, and soon-to-be New York, the company is customer-focused and all about helping support the local economy. Brendan and his partners were connected through friends and family in 2017. They committed time and capital to an initial retail project in Williamstown and became one of the first stand-alone retailers to open on the East Coast. Brendan leveraged his position as an early-mover and has since opened nearly a dozen retail and cultivation locations across three states. Check out the whole interview below. Are you a cannabis entrepreneur with a growing business and want to be interviewed? Contact us! #budsfeed #howitstarted #howitstartedvshowitsgoing #howitsmade #interview #founder #cfo #entrepreneur #newengland #maine #massachusetts #vermont #newyork https://lnkd.in/eSGcixwR
Marcus Valverde Sociedade de Advogados advised Kortex Ventures, which led an investment in Biologix , a pioneering company in the development of sleep quality tests. The BRL 6 million investment included Grupo Fleury, Grupo Sabin and Bradesco Seguros. The round also included Hospital Albert Einstein, which was already an investor and carried out a follow-on. Marcus Valverde Sociedade de Advogados advised Kortex and included partner Marcus Valverde (pictured) and associate Henry Elmadjian Rezende Leite. Read the full article >> https://lnkd.in/dVR2RzGU #TheLatinAmericanLawyer #deals #transactions #TheLatinAmericanLawyer #deals #transacions
Thrilled by Eurazeo’s H1 successes we had the pleasure to present with William Kadouch-Chassaing. Our H1 results reflected the successful execution of our strategic plan in line with our medium-term objectives presented to the market in November 2023. We reported a dynamic growth in asset management with a strong momentum in fundraising up +63% with €2.1bn raised in H1 2024, including €453M from private clients. We also increased realizations, including Amolyt Pharma (Biotech), Onfido (Venture), LumApps (Growth), EFESO Management Consultants, DORC Dutch Ophthalmic Research Center (International), Peters Surgical, and I-TRACING. We warmly thank our more than 400 great talents, as well as our clients, investors, entrepreneurs and shareholders for their trust and support in the implementation of our strategic roadmap. 🔎 Read more: https://lnkd.in/eY89RySe #PrivateEquity #AssetManagement #MidMarket #Growth #Impact #strategy #PowerBetterGrowth #results #finance
Thoughts on this? >> Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #pharmaceutical #productmarketing
It all starts with putting our clients at the center of everything you do, good things follow.
Alera Group, Inc. has earned repeat recognition in the Fast 50 list compiled by Crain's Chicago Business, which ranks us 33rd among the area’s companies with the fastest five-year growth. Earlier this year, Crain’s ranked Alera Group 73rd among Chicago’s largest privately held companies.
Retained Executive Search | Life Sciences | Healthcare | Venture Capital & Private Equity
Money Movement: New Investments, Funding Rounds, and Strategic Acquisitions Sands Capital closed its third life sciences fund, Sands Capital Life Sciences Pulse Fund III, with $555 million. AltruBio Inc. secured up to $225 million in Series B funding. BVF PARTNERS, L.P. led this round, and significant contributions came from new investors, including RA Capital Management, Soleus Capital Management, L.P., Cormorant Asset Management, LP, and Delos Capital . Pheon Therapeutics completed a $120 million Series B, led by TCGX. Other new investors include BVF PARTNERS, L.P, Lightspeed, and Perceptive Advisors. Lycia Therapeutics completed a $106.6 million Series C financing led by Venrock. New investors Janus Henderson Investors, Marshall Wace, and Franklin Templeton participated. LabGenius raised £35 million, led by M Ventures . New investors include Octopus Ventures and LG Corp. Johnson & Johnson to acquire PROTEOLOGIX Inc for $850 million in cash. Compass Executives #investments #privateequity #venturecapital #funding #mergerandacquisition
